In summary, a total of seven LUXendins now allow detection and labelling of GLP1R in five different colors, with fluorophores tailored for various imaging modalities. We anticipate that these specific and validated probes will provide further insight into GLP1R biology in the periphery and brain, with implications for treatment with GLP1RA.